Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:m.limatoxi.com >> EN >> Pharmaceutical News
China allocates 2.2b yuan to boost health sector2013-10-17
Hebei launches environmental protection teams2013-10-16
China to boost health service sector2013-10-15
Kangda planed to build Phenacetin and Lornoxicam project2013-10-14
Qilu-antibiotic's 3 APIs passed FDA examination2013-10-11
Hepalink stopped Heparin Sodium production routinely2013-10-10
GSK's China sales down 30% on bribery scandal2013-10-09
Tonglian Hulunbeier building its phase Ⅱ project2013-10-08
Pacific Biotech got Erythromycin thiocyanate production license2013-09-30
Changhai to expand Folic Acid and Sucralose capacities2013-09-29
Weiqida's Clavulanate Potassium aims USA market2013-09-27
CPSC sold 90% stock of Cenway to Changsheng2013-09-26
Zhijun's oral solid formulations got EU cGMP certificate2013-09-26
Changhai's Vitamin E project into production2013-09-26
NHU increased Vitamin A (feed grade) price2013-09-25
Yongsheng to transform vitamin E project2013-09-24
Chuanning's Erythromycin thiocyanate approved into pilot production2013-09-23
United Laboratories (Neimenggu)'s 6-APA output increases2013-09-22
India continues anti-dumping duty for China's Paracetamol2013-09-18
CCCMHPIE made first  plant extract business standards2013-09-17
Zhongsheng to ensure controlling stake in Lingsheng2013-09-17
Changfa Group bought whole stocks of Zhongrun (Neimenggu)2013-09-17
Xianju said 16-DPA price won't sharply decrease2013-09-16
Livzon's Ningxia base soon into production2013-09-13
Qiancheng and DSM to build biggest base of enzyme formulations2013-09-13
United Laboratories (Neimenggu) 6-APA output increases slightly2013-09-12
GuoBang Erythromycin products passed EU GMP2013-09-12
GSK denies it is considering leaving China2013-09-11
First generic Imatinib approved in China2013-09-11
All synthesis projects of Hisoar's Waisha factory closed2013-09-10
Vertellus to increase Nicotinamide price on Oct. 1st2013-09-09
Huamin's powder injections passed Brail GMP2013-09-09
共4532个 页次:75/142页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
Baidu
map